Please login to the form below

Not currently logged in
Email:
Password:

Dr Martine Dehlinger-Kremer becomes EUCROF president

She brings experience from SynteractHCR

EUCROF Dr Martine Delinger-KremerThe European Contract Research Organisation Foundation (EUCROF) has elected Dr Martine Dehlinger-Kremer as its president.

Representing over 300 CROs across Europe, Dr Dehlinger-Kremer will be responsible for developing the foundation's educational activities and overseeing its plans for expansion. She will continue to serve as chair of the EUCROF Paediatric Working Group, having held the post since 2008.

Dr Dehlinger-Kremer has over 30 years of clinical research industry experience and currently serves as vice president for global medical and regulatory affairs at San Diego, US-based CRO SynteractHCR.

She was recently appointed chair of the European Forum for Good Clinical Practice Children's Medicines Working Party, and has been a member of the EMA's working groups, Paediatric Network since 2013.

Wendel Barr, chief executive of SynteractHCR, said: “Dr. Dehlinger-Kremer has shown her commitment to advancing clinical research throughout her career.

“She exemplifies our mission at SynteractHCR of developing a better future for patients by bringing expertise to clinical development - and this additional position at EUCROF furthers that goal.

“We congratulate her on this honour and recognition of her expertise.”

20th December 2016

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Devil_in_the_edetail.png
The Devil is in the E-Detail
All too often, pharma companies are relying on the e-detailing approach, and missing a big opportunity to engage with their customers, build relationships, and add value....
Medical Translations: Why you need to get it right the first time
British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors....
Digital disruption
How pharma is keeping up with the pace of change...

Infographics